BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/27/2015 4:29:00 PM | Browse: 1405 | Download: 2576
 |
Received |
|
2014-10-15 08:18 |
|
Peer-Review Started |
|
2014-10-15 10:43 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-11-18 15:03 |
|
Revised |
|
2014-11-27 06:26 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-01-10 12:27 |
|
Second Decision by Editor-in-Chief |
|
2015-01-11 04:25 |
|
Final Decision by Editorial Office Director |
|
2015-01-16 18:12 |
|
Articles in Press |
|
2015-01-16 18:18 |
|
Edit the Manuscript by Language Editor |
|
2015-02-03 19:28 |
|
Typeset the Manuscript |
|
2015-04-13 15:54 |
|
Publish the Manuscript Online |
|
2015-04-27 16:22 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Clinical Trial |
| Article Title |
Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jae Jin Hwang, Dong Ho Lee, Ae-Ra Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park and Nayoung Kim |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dong Ho Lee, MD, Department of Internal Medicine, Seoul National University Bundang Hospital, No. 300 Gumi-dong, Bundang-gu, Seongnam 463-707, Gyeonggi-do, South Korea. dhljohn@yahoo.co.kr |
| Key Words |
Helicobacter pylori; First-line eradication treatment; Moxifloxacin; Sequential therapy; Eradication rate |
| Core Tip |
This is the first study to evaluate the efficacy of 14-d moxifloxacin-based sequential therapy compared to that of 14-d clarithromycin-based sequential therapy as a first-line eradication treatment of Helicobacter pylori infection. Our study showed that the moxifloxacin-based therapy is effective and shows excellent patient compliance and safety compared with the clarithromycin-based sequential therapy. The high eradication rate, excellent compliance, and safety of the moxifloxacin-based sequential therapy suggest its suitability as an alternative to standard triple therapy. |
| Publish Date |
2015-04-27 16:22 |
| Citation |
Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease. World J Gastroenterol 2015; 21(16): 5032-5038 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i16/5032.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i16.5032 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
